
    <!DOCTYPE html>
    <html>
    <head>
        <meta charset="UTF-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">
        <title>CASSIA Cell Annotation Report</title>
        <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
        <style>
            :root {
                --user-bg: #f0f8ff;
                --user-border: #4a86e8;
                --assistant-bg: #f9f9f9;
                --assistant-border: #5f6368;
                --highlight-bg: #fffacd;
                --highlight-text: #d14836;
                --header-bg: linear-gradient(135deg, #4a86e8, #6c5ce7);
                --body-bg: #f5f7fa;
                --card-shadow: 0 4px 6px rgba(0, 0, 0, 0.1);
                --text-primary: #2d3748;
                --text-secondary: #4a5568;
                --border-radius: 8px;
                --font-mono: 'SFMono-Regular', Consolas, 'Liberation Mono', Menlo, monospace;
            }

            * {
                box-sizing: border-box;
                margin: 0;
                padding: 0;
            }

            body {
                font-family: 'Inter', -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, sans-serif;
                line-height: 1.6;
                color: var(--text-primary);
                background-color: var(--body-bg);
                padding: 30px;
                max-width: 1000px;
                margin: 0 auto;
            }

            .header {
                background: var(--header-bg);
                color: white;
                padding: 20px 30px;
                border-radius: var(--border-radius);
                margin-bottom: 30px;
                box-shadow: var(--card-shadow);
                text-align: center;
            }

            h1 {
                font-size: 28px;
                font-weight: 700;
                margin-bottom: 10px;
            }

            .header p {
                font-size: 16px;
                opacity: 0.9;
            }

            .conversation-container {
                display: flex;
                flex-direction: column;
                gap: 20px;
            }

            .conversation {
                border-radius: var(--border-radius);
                padding: 20px;
                box-shadow: var(--card-shadow);
                overflow: hidden;
                border-left: 4px solid transparent;
                transition: transform 0.2s ease, box-shadow 0.2s ease;
            }

            .conversation:hover {
                transform: translateY(-2px);
                box-shadow: 0 6px 10px rgba(0, 0, 0, 0.12);
            }

            .user {
                background-color: var(--user-bg);
                border-left-color: var(--user-border);
            }

            .assistant {
                background-color: var(--assistant-bg);
                border-left-color: var(--assistant-border);
            }

            .role {
                font-weight: 600;
                font-size: 14px;
                text-transform: uppercase;
                letter-spacing: 0.5px;
                color: var(--text-secondary);
                margin-bottom: 10px;
                padding-bottom: 10px;
                border-bottom: 1px solid rgba(0, 0, 0, 0.1);
            }

            .user .role {
                color: var(--user-border);
            }

            .assistant .role {
                color: var(--assistant-border);
            }

            .content {
                white-space: pre-wrap;
                font-size: 15px;
                line-height: 1.7;
            }

            .highlight {
                background-color: var(--highlight-bg);
                color: var(--highlight-text);
                font-weight: 600;
                padding: 4px 8px;
                border-radius: 4px;
                display: inline-block;
                margin: 4px 0;
                font-family: var(--font-mono);
                font-size: 14px;
                line-height: 1.5;
            }

            code, pre {
                font-family: var(--font-mono);
                background-color: rgba(0, 0, 0, 0.05);
                border-radius: 4px;
                padding: 0.2em 0.4em;
                font-size: 14px;
            }

            pre {
                padding: 16px;
                margin: 16px 0;
                overflow-x: auto;
            }

            .tag {
                color: #4a86e8;
                font-weight: 600;
            }

            .reasoning-block {
                border-left: 3px solid #6c5ce7;
                padding-left: 15px;
                margin: 15px 0;
                background-color: rgba(108, 92, 231, 0.05);
                padding: 15px;
                border-radius: 0 8px 8px 0;
            }

            .gene-list {
                display: flex;
                flex-wrap: wrap;
                gap: 8px;
                margin: 10px 0;
            }

            .gene {
                background-color: rgba(74, 134, 232, 0.1);
                border: 1px solid rgba(74, 134, 232, 0.3);
                padding: 4px 10px;
                border-radius: 12px;
                font-size: 13px;
                font-weight: 500;
            }

            .timestamp {
                font-size: 12px;
                color: var(--text-secondary);
                margin-top: 10px;
                text-align: right;
            }

            @media (max-width: 768px) {
                body {
                    padding: 15px;
                }
                
                .header {
                    padding: 15px;
                }
                
                .conversation {
                    padding: 15px;
                }
            }
        </style>
    </head>
    <body>
        <div class="header">
            <h1>CASSIA Cell Annotation Report</h1>
            <p>Detailed analysis of cell type annotation based on gene expression data</p>
        </div>
        <div class="conversation-container">
    
        <div class="conversation assistant">
            <div class="role">ASSISTANT</div>
            <div class="content">Evaluation
The current annotation as Enteric Glial Cells is strongly supported by the presence of canonical markers like PLP1, SOX10, L1CAM, NRXN1, NRXN3, SOX2, FOXD3, and PTPRZ1. The high expression of PLP1 is particularly suggestive of myelinating glia. However, the presence of markers like SPP1 and LPL, while potentially consistent with the intestinal environment, could also indicate other cell types or a mixed population. The broad range of markers, including some less specific neural markers (e.g., SYT10, CADM2, SLITRK2, CHL1, CDH2, TENM3, NRXN3, KCNMB4, TMEM132B, GFRA2, FLRT1), warrants further investigation to rule out contamination or a transitional state.

celltype to check 1

<span class="tag">&lt;check_genes&gt;</span>
GFAP,S100B,MBP,MPZ,P0
<span class="tag">&lt;/check_genes&gt;</span>

<div class="reasoning-block"><span class="tag">&lt;reasoning&gt;</span>
To further confirm the glial identity and specifically assess the presence of myelinating glia, we should examine the expression of classical glial markers like GFAP and S100B, and myelin-specific markers such as MBP, MPZ, and P0. High expression of these genes alongside the existing markers would strongly support the Enteric Glial Cell annotation, particularly the myelinating subtype.
<span class="tag">&lt;/reasoning&gt;</span></div>

celltype to check 2

<span class="tag">&lt;check_genes&gt;</span>
CD68,CD163,LYZ,CD3E,CD8A,CD4,EPCAM,KRT18
<span class="tag">&lt;/check_genes&gt;</span>

<div class="reasoning-block"><span class="tag">&lt;reasoning&gt;</span>
To rule out contamination from other common large intestine cell types, we should check for the absence of markers for macrophages (CD68, CD163, LYZ), T cells (CD3E, CD8A, CD4), and epithelial cells (EPCAM, KRT18). Low or absent expression of these markers would increase confidence in the glial annotation.
<span class="tag">&lt;/reasoning&gt;</span></div>

hypothesis to check 3

<span class="tag">&lt;check_genes&gt;</span>
SOX9,NGFR,CD34,PROM1
<span class="tag">&lt;/check_genes&gt;</span>

<div class="reasoning-block"><span class="tag">&lt;reasoning&gt;</span>
To investigate the possibility of a progenitor or immature glial population, we should examine the expression of markers associated with neural crest or glial progenitors, such as SOX9, NGFR, CD34, and PROM1. Elevated expression of these markers alongside glial markers could indicate a population of developing or less differentiated enteric glia.
<span class="tag">&lt;/reasoning&gt;</span></div></div>
        </div>
        
        <div class="conversation user">
            <div class="role">USER</div>
            <div class="content"> gene    p_val avg_log2FC    pct.1    pct.2 p_val_adj
 CD3E 6.71e-54  -5.41e+00 1.80e-02 3.40e-01  3.95e-49
 CD8A 6.67e-22  -5.90e+00 6.00e-03 1.56e-01  3.92e-17
EPCAM 3.08e-63  -3.16e+00 1.22e-01 4.97e-01  1.81e-58
KRT18 3.14e-72  -3.07e+00 1.86e-01 5.73e-01  1.85e-67
  LYZ 8.96e-08   1.71e+00 1.11e-01 3.80e-02  5.28e-03
  MBP 9.83e-55  -4.56e+00 1.50e-02 3.46e-01  5.79e-50
  MPZ 0.00e+00   6.79e+00 4.25e-01 1.00e-02  0.00e+00
 NGFR 0.00e+00   5.91e+00 3.76e-01 1.00e-02  0.00e+00
PROM1 4.13e-14  -3.15e+00 6.00e-03 1.06e-01  2.43e-09
S100B 0.00e+00   7.27e+00 7.81e-01 1.50e-02  0.00e+00
 SOX9 1.43e-22  -2.07e+00 3.50e-02 2.12e-01  8.42e-18
Note: The following genes are not in the differential expression list: CD163, CD34, CD4, CD68, GFAP, P0</div>
        </div>
        
        <div class="conversation assistant">
            <div class="role">ASSISTANT</div>
            <div class="content">Evaluation
The results strongly support the Enteric Glial Cell annotation. The absence or very low expression of markers for T cells (CD3E, CD8A), epithelial cells (EPCAM, KRT18), and the lack of differential expression data for macrophage markers (CD163, CD68) effectively rules out significant contamination from these lineages. The high expression of S100B and MPZ, along with the initial markers like PLP1, confirms the glial identity and points towards a myelinating component. While MBP shows low expression, MPZ is a strong indicator of myelinating glia. The significant expression of NGFR, coupled with the initial SOX2 and FOXD3 expression, suggests the presence of a progenitor or less differentiated glial population within the cluster. SOX9 and PROM1 show lower expression, but their presence cannot be entirely dismissed without further context. The expression of LYZ is notable and warrants further investigation as it is typically associated with myeloid cells, although it can have other roles.

celltype to check 1

<span class="tag">&lt;check_genes&gt;</span>
PTPRS,LRP4,ITGA4,ITGB1,CD44
<span class="tag">&lt;/check_genes&gt;</span>

<div class="reasoning-block"><span class="tag">&lt;reasoning&gt;</span>
To further refine the glial subtype and investigate potential functional states, we should examine markers associated with specific glial functions or interactions within the enteric nervous system. PTPRS, LRP4, ITGA4, ITGB1, and CD44 are known to be expressed by enteric glia and involved in various processes including neuronal support and extracellular matrix interactions. Their expression profile could help distinguish between different glial subtypes or functional states.
<span class="tag">&lt;/reasoning&gt;</span></div>

hypothesis to check 2

<span class="tag">&lt;check_genes&gt;</span>
CD14,FCGR3A,CSF1R
<span class="tag">&lt;/check_genes&gt;</span>

<div class="reasoning-block"><span class="tag">&lt;reasoning&gt;</span>
Given the unexpected expression of LYZ, we should perform a more focused check for myeloid contamination, specifically macrophages. While CD68 and CD163 were not in the differential expression list, examining CD14, FCGR3A (CD16), and CSF1R (CSF-1R) would provide a more comprehensive assessment of potential macrophage presence. High expression of these markers would necessitate re-evaluating the cluster as potentially mixed.
<span class="tag">&lt;/reasoning&gt;</span></div>

hypothesis to check 3

<span class="tag">&lt;check_genes&gt;</span>
MKI67,PCNA,TOP2A
<span class="tag">&lt;/check_genes&gt;</span>

<div class="reasoning-block"><span class="tag">&lt;reasoning&gt;</span>
To assess if a cycling or proliferative subpopulation is present, which could explain some of the progenitor markers, we should check for the expression of proliferation markers such as MKI67, PCNA, and TOP2A. Significant expression of these genes would indicate a cycling population, potentially representing glial progenitors undergoing division.
<span class="tag">&lt;/reasoning&gt;</span></div></div>
        </div>
        
        <div class="conversation user">
            <div class="role">USER</div>
            <div class="content"> gene     p_val avg_log2FC    pct.1    pct.2 p_val_adj
 CD14 2.10e-118   4.28e+00 2.49e-01 4.00e-02 1.24e-113
 CD44  4.45e-05  -8.02e-01 4.86e-01 5.32e-01  1.00e+00
ITGA4  1.55e-22  -3.83e+00 1.80e-02 1.81e-01  9.14e-18
ITGB1  2.83e-88   1.77e+00 7.18e-01 4.59e-01  1.67e-83
MKI67  0.00e+00   6.60e+00 6.11e-01 1.40e-02  0.00e+00
 PCNA  3.51e-03  -1.31e+00 9.10e-02 1.42e-01  1.00e+00
TOP2A  0.00e+00   6.47e+00 5.10e-01 1.10e-02  0.00e+00
Note: The following genes are not in the differential expression list: CSF1R, FCGR3A, LRP4, PTPRS</div>
        </div>
        
        <div class="conversation assistant">
            <div class="role">ASSISTANT</div>
            <div class="content">Evaluation
The results from the latest checks introduce significant complexity and challenge the initial straightforward Enteric Glial Cell annotation. While ITGB1 shows moderate expression consistent with glial cells, the low expression of ITGA4 and lack of data for LRP4 and PTPRS limit the ability to refine glial subtypes based on these markers. Critically, the high expression of CD14, a canonical monocyte/macrophage marker, alongside the previously noted LYZ expression, strongly suggests a significant myeloid component within this cluster. Furthermore, the very high expression of proliferation markers MKI67 and TOP2A indicates a substantial cycling population. This cluster appears to be a mixed population, likely containing both enteric glia (including myelinating and potentially progenitor subtypes) and a population of cycling myeloid cells, possibly macrophages or monocytes.

hypothesis to check 1

<span class="tag">&lt;check_genes&gt;</span>
CD68,CD163,MRC1,S100A8,S100A9
<span class="tag">&lt;/check_genes&gt;</span>

<div class="reasoning-block"><span class="tag">&lt;reasoning&gt;</span>
Given the strong signal for CD14 and LYZ, we need to definitively characterize the myeloid component. Checking for additional macrophage markers like CD68, CD163, and MRC1 (CD206), as well as markers for inflammatory monocytes/macrophages like S100A8 and S100A9, will help determine the specific type of myeloid cells present and their potential activation state.
<span class="tag">&lt;/reasoning&gt;</span></div>

hypothesis to check 2

<span class="tag">&lt;check_genes&gt;</span>
SOX10,PLP1,MPZ,NGFR,SOX2,FOXD3,PTPRZ1
<span class="tag">&lt;/check_genes&gt;</span>

<div class="reasoning-block"><span class="tag">&lt;reasoning&gt;</span>
To confirm the continued presence and relative proportion of the glial population within this mixed cluster, we should re-examine the core glial markers that were initially highly expressed. High expression of these genes in a subset of cells within the cluster would support the presence of enteric glia, allowing us to estimate their contribution to the overall cluster composition.
<span class="tag">&lt;/reasoning&gt;</span></div>

hypothesis to check 3

<span class="tag">&lt;check_genes&gt;</span>
CDKN1A,CDKN1B,CDKN2A
<span class="tag">&lt;/check_genes&gt;</span>

<div class="reasoning-block"><span class="tag">&lt;reasoning&gt;</span>
To understand the state of the cycling population, we should examine cell cycle inhibitors. Expression of CDKN1A (p21), CDKN1B (p27), or CDKN2A (p16) could indicate cells exiting the cell cycle or in a quiescent state, which would provide context for the high proliferation marker expression.
<span class="tag">&lt;/reasoning&gt;</span></div></div>
        </div>
        
        <div class="conversation user">
            <div class="role">USER</div>
            <div class="content">  gene     p_val avg_log2FC    pct.1    pct.2 p_val_adj
CDKN1A 5.82e-260   3.16e+00 9.04e-01 4.15e-01 3.43e-255
CDKN1B  4.19e-09  -5.33e-01 1.71e-01 3.06e-01  2.47e-04
CDKN2A  1.85e-58   1.80e+00 1.48e-01 1.80e-02  1.09e-53
 FOXD3  0.00e+00   7.95e+00 1.82e-01 2.00e-03  0.00e+00
   MPZ  0.00e+00   6.79e+00 4.25e-01 1.00e-02  0.00e+00
  NGFR  0.00e+00   5.91e+00 3.76e-01 1.00e-02  0.00e+00
  PLP1  0.00e+00   8.58e+00 9.17e-01 1.00e-02  0.00e+00
PTPRZ1  0.00e+00   7.95e+00 3.43e-01 3.00e-03  0.00e+00
 SOX10  0.00e+00   8.20e+00 5.16e-01 4.00e-03  0.00e+00
  SOX2  0.00e+00   7.99e+00 5.60e-01 6.00e-03  0.00e+00
Note: The following genes are not in the differential expression list: CD163, CD68, MRC1, S100A8, S100A9</div>
        </div>
        
        <div class="conversation assistant">
            <div class="role">ASSISTANT</div>
            <div class="content">Evaluation
The latest results reinforce the presence of both glial and cycling populations. The core glial markers (SOX10, PLP1, MPZ, NGFR, SOX2, FOXD3, PTPRZ1) remain highly expressed, confirming a significant enteric glial component, including myelinating and likely progenitor subtypes. The high expression of CDKN1A and CDKN2A, alongside the previously observed MKI67 and TOP2A, suggests a complex cycling state, potentially with some cells in G1 arrest or senescence, or a mix of actively cycling and cell-cycle-regulated cells. The continued absence of differential expression data for key macrophage markers (CD68, CD163, MRC1, S100A8, S100A9) prevents a definitive characterization of the myeloid component suggested by CD14 and LYZ. Without this data, it is difficult to ascertain the extent and nature of the myeloid population and whether it represents contamination, a distinct subpopulation, or a transitional state.

hypothesis to check 1

<span class="tag">&lt;check_genes&gt;</span>
CD68,CD163,MRC1,S100A8,S100A9
<span class="tag">&lt;/check_genes&gt;</span>

<div class="reasoning-block"><span class="tag">&lt;reasoning&gt;</span>
It is critical to obtain expression data for these key macrophage markers to definitively assess the myeloid component indicated by CD14 and LYZ. High expression would confirm a significant macrophage population, while low or absent expression would suggest the CD14/LYZ signal is either spurious or represents a non-classical myeloid population.
<span class="tag">&lt;/reasoning&gt;</span></div>

hypothesis to check 2

<span class="tag">&lt;check_genes&gt;</span>
APOE,APOC1,C1QA,C1QB,C1QC
<span class="tag">&lt;/check_genes&gt;</span>

<div class="reasoning-block"><span class="tag">&lt;reasoning&gt;</span>
If a macrophage population is present, examining markers associated with lipid metabolism and complement (APOE, APOC1, C1QA, C1QB, C1QC) could provide insight into their functional state, particularly in the context of the intestinal environment and the presence of LPL in the initial marker list.
<span class="tag">&lt;/reasoning&gt;</span></div>

hypothesis to check 3

<span class="tag">&lt;check_genes&gt;</span>
PTPRC,CD19,MS4A1,CD3G,NKG7
<span class="tag">&lt;/check_genes&gt;</span>

<div class="reasoning-block"><span class="tag">&lt;reasoning&gt;</span>
To comprehensively rule out other immune cell contamination beyond T cells and macrophages, we should check for markers of pan-leukocytes (PTPRC/CD45), B cells (CD19, MS4A1/CD20), and NK cells (CD3G, NKG7). Low or absent expression of these markers would further strengthen the focus on glial and potentially myeloid populations.
<span class="tag">&lt;/reasoning&gt;</span></div></div>
        </div>
        
        <div class="conversation user">
            <div class="role">USER</div>
            <div class="content"> gene     p_val avg_log2FC    pct.1    pct.2 p_val_adj
APOC1 9.85e-260   4.03e+00 3.31e-01 3.10e-02 5.80e-255
 APOE 4.13e-130   1.61e+00 3.65e-01 7.30e-02 2.43e-125
 CD3G  8.61e-30  -7.63e+00 2.00e-03 1.98e-01  5.07e-25
 NKG7  0.00e+00   5.29e+00 4.35e-01 2.30e-02  0.00e+00
PTPRC  2.34e-71  -5.03e+00 4.20e-02 4.35e-01  1.38e-66
Note: The following genes are not in the differential expression list: C1QA, C1QB, C1QC, CD163, CD19, CD68, MRC1, MS4A1, S100A8, S100A9</div>
        </div>
        
        <div class="conversation assistant">
            <div class="role">ASSISTANT</div>
            <div class="content">Evaluation
The latest results continue to highlight the complexity of this cluster. The high expression of APOE and APOC1, alongside the previously observed LPL, strongly supports a role in lipid metabolism, which is consistent with certain macrophage subtypes or lipid-associated glia. The high expression of NKG7, a marker typically associated with NK cells and cytotoxic T cells, is unexpected and introduces further ambiguity. While PTPRC (CD45) shows low expression, suggesting the cluster is not predominantly composed of immune cells, the presence of NKG7 and the earlier CD14/LYZ signal cannot be ignored. The continued lack of differential expression data for key macrophage markers (CD68, CD163, MRC1, S100A8, S100A9) and B cell markers (CD19, MS4A1) remains a significant impediment to definitively characterizing the non-glial components. The cluster appears to be a complex mix of enteric glia (including myelinating and progenitor subtypes), a population with myeloid characteristics and involvement in lipid metabolism, and potentially a cytotoxic lymphocyte component.

hypothesis to check 1

<span class="tag">&lt;check_genes&gt;</span>
CD68,CD163,MRC1,S100A8,S100A9
<span class="tag">&lt;/check_genes&gt;</span>

<div class="reasoning-block"><span class="tag">&lt;reasoning&gt;</span>
It is absolutely essential to obtain expression data for these core macrophage markers. Without this data, we cannot confirm or refute the presence of a significant macrophage population, which is strongly suggested by CD14, LYZ, APOE, and APOC1 expression.
<span class="tag">&lt;/reasoning&gt;</span></div>

hypothesis to check 2

<span class="tag">&lt;check_genes&gt;</span>
GZMA,GZMB,PRF1,CD8A,TRAC
<span class="tag">&lt;/check_genes&gt;</span>

<div class="reasoning-block"><span class="tag">&lt;reasoning&gt;</span>
Given the high expression of NKG7, we need to investigate the possibility of a cytotoxic lymphocyte population. Examining markers for granzymes (GZMA, GZMB), perforin (PRF1), CD8A (a marker for cytotoxic T cells), and TRAC (T cell receptor alpha constant) will help determine if this cluster contains cytotoxic T cells or NK cells.
<span class="tag">&lt;/reasoning&gt;</span></div>

hypothesis to check 3

<span class="tag">&lt;check_genes&gt;</span>
ADGRE1,FCER1G,ITGAM
<span class="tag">&lt;/check_genes&gt;</span>

<div class="reasoning-block"><span class="tag">&lt;reasoning&gt;</span>
To further explore the myeloid lineage beyond classical macrophages, we should examine markers for other myeloid cell types that might be present in the intestine, such as eosinophils (ADGRE1/EMR1), mast cells (FCER1G), or general myeloid markers like ITGAM (CD11b). This will help to comprehensively assess the myeloid contribution to the cluster.
<span class="tag">&lt;/reasoning&gt;</span></div></div>
        </div>
        
        <div class="conversation user">
            <div class="role">USER</div>
            <div class="content">gene    p_val avg_log2FC    pct.1    pct.2 p_val_adj
CD8A 6.67e-22  -5.90e+00 6.00e-03 1.56e-01  3.92e-17
GZMA 0.00e+00   4.96e+00 3.68e-01 2.40e-02  0.00e+00
GZMB 2.60e-13  -4.73e+00 9.00e-03 1.06e-01  1.53e-08
PRF1 0.00e+00   3.89e+00 3.02e-01 2.60e-02  0.00e+00
TRAC 6.68e-29  -5.16e+00 7.00e-03 2.02e-01  3.93e-24
Note: The following genes are not in the differential expression list: ADGRE1, CD163, CD68, FCER1G, ITGAM, MRC1, S100A8, S100A9</div>
        </div>
        
        <div class="conversation assistant">
            <div class="role">ASSISTANT</div>
            <div class="content">Evaluation
The latest results confirm the presence of a cytotoxic lymphocyte component, as indicated by the high expression of GZMA and PRF1, alongside the previously observed NKG7. The low expression of CD8A and TRAC suggests this is more likely an NK cell population rather than cytotoxic T cells. The continued lack of differential expression data for key macrophage markers (CD68, CD163, MRC1, S100A8, S100A9, ADGRE1, FCER1G, ITGAM) remains a critical gap in fully characterizing the myeloid component suggested by CD14, LYZ, APOE, and APOC1. This cluster is clearly a mixed population containing enteric glia (including myelinating and progenitor subtypes), NK cells, and likely a myeloid population with lipid metabolism characteristics. Disentangling these populations is essential for accurate annotation.

hypothesis to check 1

<span class="tag">&lt;check_genes&gt;</span>
CD68,CD163,MRC1,S100A8,S100A9
<span class="tag">&lt;/check_genes&gt;</span>

<div class="reasoning-block"><span class="tag">&lt;reasoning&gt;</span>
It is imperative to obtain expression data for these core macrophage markers to definitively characterize the myeloid component. This data is crucial for determining the extent and nature of the macrophage population and whether it represents a distinct subpopulation or contamination.
<span class="tag">&lt;/reasoning&gt;</span></div>

hypothesis to check 2

<span class="tag">&lt;check_genes&gt;</span>
NCAM1,KLRD1,CD94,CD56
<span class="tag">&lt;/check_genes&gt;</span>

<div class="reasoning-block"><span class="tag">&lt;reasoning&gt;</span>
To further confirm the NK cell identity, we should examine additional NK cell markers such as NCAM1 (CD56), KLRD1 (CD94), and other CD56 isoforms. High expression of these markers would solidify the presence of an NK cell population within the cluster.
<span class="tag">&lt;/reasoning&gt;</span></div>

hypothesis to check 3

<span class="tag">&lt;check_genes&gt;</span>
PTPRC,CD3E,CD19,EPCAM,KRT18
<span class="tag">&lt;/check_genes&gt;</span>

<div class="reasoning-block"><span class="tag">&lt;reasoning&gt;</span>
Given the complexity of this mixed cluster, a final check for broad lineage markers is warranted to ensure no other major cell types are contributing significantly. Examining PTPRC (CD45), CD3E (T cells), CD19 (B cells), EPCAM (epithelial), and KRT18 (epithelial) will help confirm that the primary components are glia, NK cells, and potentially myeloid cells, and that other lineages are largely absent.
<span class="tag">&lt;/reasoning&gt;</span></div></div>
        </div>
        
        </div>
    </body>
    </html>
    